139 related articles for article (PubMed ID: 10982813)
1. Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells.
Seo BB; Wang J; Flotte TR; Yagi T; Matsuno-Yagi A
J Biol Chem; 2000 Dec; 275(48):37774-8. PubMed ID: 10982813
[TBL] [Abstract][Full Text] [Related]
2. Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae.
Seo BB; Matsuno-Yagi A; Yagi T
Biochim Biophys Acta; 1999 May; 1412(1):56-65. PubMed ID: 10354494
[TBL] [Abstract][Full Text] [Related]
3. Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells.
Seo BB; Kitajima-Ihara T; Chan EK; Scheffler IE; Matsuno-Yagi A; Yagi T
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9167-71. PubMed ID: 9689052
[TBL] [Abstract][Full Text] [Related]
4. Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene.
Bai Y; Hájek P; Chomyn A; Chan E; Seo BB; Matsuno-Yagi A; Yagi T; Attardi G
J Biol Chem; 2001 Oct; 276(42):38808-13. PubMed ID: 11479321
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
6. In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Matsuno-Yagi A; Yagi T
J Biol Chem; 2006 May; 281(20):14250-5. PubMed ID: 16543240
[TBL] [Abstract][Full Text] [Related]
7. Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells.
Kitajima-Ihara T; Yagi T
FEBS Lett; 1998 Jan; 421(1):37-40. PubMed ID: 9462835
[TBL] [Abstract][Full Text] [Related]
8. A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Yagi T; Matsuno-Yagi A
Mol Ther; 2002 Sep; 6(3):336-41. PubMed ID: 12231169
[TBL] [Abstract][Full Text] [Related]
9. Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Kao MC; Matsuno-Yagi A
Rejuvenation Res; 2006; 9(2):191-7. PubMed ID: 16706641
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for complex I deficiencies.
Seo BB; Nakamaru-Ogiso E; Cruz P; Flotte TR; Yagi T; Matsuno-Yagi A
Hum Gene Ther; 2004 Sep; 15(9):887-95. PubMed ID: 15353043
[TBL] [Abstract][Full Text] [Related]
11. Xenotransplantation of mitochondrial electron transfer enzyme, Ndi1, in myocardial reperfusion injury.
Perry CN; Huang C; Liu W; Magee N; Carreira RS; Gottlieb RA
PLoS One; 2011 Feb; 6(2):e16288. PubMed ID: 21339825
[TBL] [Abstract][Full Text] [Related]
12. Roles of bound quinone in the single subunit NADH-quinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae.
Yamashita T; Nakamaru-Ogiso E; Miyoshi H; Matsuno-Yagi A; Yagi T
J Biol Chem; 2007 Mar; 282(9):6012-20. PubMed ID: 17200125
[TBL] [Abstract][Full Text] [Related]
13. Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model.
Barber-Singh J; Seo BB; Matsuno-Yagi A; Yagi T
Parkinsons Dis; 2010 Dec; 2011():438370. PubMed ID: 21188192
[TBL] [Abstract][Full Text] [Related]
14. Possibility of transkingdom gene therapy for complex I diseases.
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Matsuno-Yagi A
Biochim Biophys Acta; 2006; 1757(5-6):708-14. PubMed ID: 16581014
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.
Chadderton N; Palfi A; Millington-Ward S; Gobbo O; Overlack N; Carrigan M; O'Reilly M; Campbell M; Ehrhardt C; Wolfrum U; Humphries P; Kenna PF; Farrar GJ
Eur J Hum Genet; 2013 Jan; 21(1):62-8. PubMed ID: 22669418
[TBL] [Abstract][Full Text] [Related]
16. Reaction mechanism of single subunit NADH-ubiquinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae: evidence for a ternary complex mechanism.
Yang Y; Yamashita T; Nakamaru-Ogiso E; Hashimoto T; Murai M; Igarashi J; Miyoshi H; Mori N; Matsuno-Yagi A; Yagi T; Kosaka H
J Biol Chem; 2011 Mar; 286(11):9287-97. PubMed ID: 21220430
[TBL] [Abstract][Full Text] [Related]
17. Gene cluster of the energy-transducing NADH-quinone oxidoreductase of Paracoccus denitrificans: characterization of four structural gene products.
Xu X; Matsuno-Yagi A; Yagi T
Biochemistry; 1992 Aug; 31(30):6925-32. PubMed ID: 1637825
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.
Marella M; Seo BB; Yagi T; Matsuno-Yagi A
J Bioenerg Biomembr; 2009 Dec; 41(6):493-7. PubMed ID: 19904590
[TBL] [Abstract][Full Text] [Related]
19. Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.
Marella M; Seo BB; Nakamaru-Ogiso E; Greenamyre JT; Matsuno-Yagi A; Yagi T
PLoS One; 2008 Jan; 3(1):e1433. PubMed ID: 18197244
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with Single-Subunit Yeast NADH-Ubiquinone Oxidoreductase (NDI1) Improves the Visual Function in Experimental Autoimmune Encephalomyelitis (EAE) Mice Model of Multiple Sclerosis (MS).
Talla V; Koilkonda R; Guy J
Mol Neurobiol; 2020 Apr; 57(4):1952-1965. PubMed ID: 31900864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
